Skip to main content

Military Health System

USU cohort study investigates COVID-19 impacts on DOD personnel

Image of Military health personnel wearing a mask and a face shield holding up a sign that has the number eighteen on it . Navy Hospital Corpsman 3rd Class Charles Cambern holds up a numbered sign as patients circle through to receive the COVID-19 vaccine at Walter Reed National Military Medical Center, in Bethesda, Maryland. WRNMMC is one of 10 DOD sites undertaking the EPICC study to better understand COVID-19 disease. (U.S. Navy photo by Ricardo Reyes)

Recommended Content:

Immunizations | COVID-19 Vaccine Efforts | Coronavirus & the MHS Response

The Uniformed Services University of the Health Sciences’ Infectious Disease Clinical Research Program is leading a multi-year study to identify risk factors for COVID-19 in the military population, understand the symptoms and disease course, and investigate clinical outcomes.

Epidemiology, Immunology, and Clinical Characteristics of Emerging Infectious Diseases with Pandemic Potential – or EPICC – study hopes to inform the Military Health System on ways to improve the patient care and treatment, infection, and disease prevention of those with COVID-19. USU is working in partnership with a network of military commands, treatment facilities, and laboratories across the country for EPICC.

Findings from the study “will support further understanding of the impact of SARS-COV-2 infection on active-duty readiness, acute and chronic clinical outcomes, the effectiveness of new treatments and vaccines, and address questions related to the emergence of new variants and their clinical impact,” said Dr. Brian Agan, deputy science director of IDCRP and principal investigator of the study.

The study is also evaluating how long the immune response to the COVID-19 vaccines lasts, breakthrough infections – which happen when a vaccinated individual becomes sick from the same illness the vaccination is designed to prevent – and how they behave over time, and estimating vaccine effectiveness, said Agan, who is also an employee of the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.

Department of Defense service members and MHS beneficiaries of any age with COVID-19-like illness who are admitted to the hospital or treated as outpatients at an EPICC site can join. Likewise, those 18 years or older who have been tested for COVID-19, whether they tested positive or negative, can participate in the online portion of the study, which includes self-collected blood specimens for selected participants.

The protocol was recently updated to also enroll COVID-19 vaccine recipients and will initiate recruitment upon approval, said Navy Capt. (Dr.) Timothy Burgess, program director of IDCRP, who oversees the study. Eligible beneficiaries who are interested in participating in EPICC can submit an online screening form to join.

“In addition, asymptomatic individuals with a high risk of exposure are also eligible for enrollment in EPICC, which includes health care workers and close contacts of cases,” said Burgess. “Particularly, health care workers who have received a COVID-19 vaccination will be an important population for studies to examine vaccine effectiveness and outcomes.”

Data from inpatient, outpatient, and online participants, including their clinical characteristics, comorbidities, the clinical course of their illness, treatment, immunology, and outcomes, is being collected for the study.

“Questionnaires are provided to enrollees to collect information on demographics, symptoms at initial presentation and chronic or persisting symptoms during follow-up, exposure history, and lifestyle factors,” said Burgess. “Clinical and research specimens collected from enrollees are examined using molecular, serological, and other immune assays in collaboration USU and non-USU partner laboratories.”

Initiated in March 2020, EPICC is expected to continue enrolling participants at least through March 2022, or for as long as needed to fill in the knowledge gaps related to this disease, explained Agan.

“Once enrolled, participants are actively followed for one year to fully capture specimens and data including chronic outcomes and sequelae and will be followed for up to four additional years through electronic medical record review,” Agan said.

EPICC is being conducted at 10 military medical treatment facilities throughout the United States:

  • Brooke Army Medical Center in Fort Sam Houston, Texas
  • Carl R. Darnall Army Medical Center in Fort Hood, Texas
  • Fort Belvoir Community Hospital in Fort Belvoir, Virginia
  • Joint Base Lewis-McChord, Washington
  • Naval Medical Center Portsmouth in Portsmouth, Virginia
  • Naval Medical Center San Diego in San Diego, California
  • Tripler Army Medical Center in Honolulu, Hawaii
  • William Beaumont Army Medical Center in El Paso, Texas
  • Womack Army Medical Center in Fort Bragg, North Carolina
  • Walter Reed National Military Medical Center in Bethesda, Maryland

Military health personnel wearing a face mask and shield speaking to a man who is wearing a face mask
Navy Hospital Corpsman 3rd Class Michael A. Torrent conducts a pre-screening questionnaire prior to administering the COVID-19 vaccine as part of Operation Warp Speed at Walter Reed National Military Medical Center. (U.S. Navy photo by Ricardo Reyes)

By the first week of February, more than 1,600 active-duty service members and MHS beneficiaries had enrolled in EPICC, the majority of whom are being treated as outpatients, said Agan. Approximately half of the subjects with confirmed SARS-CoV-2 diagnoses included in EPICC are active-duty service members.

Some interesting observations the researchers found thus far are that the characteristics of hospitalized COVID-19 patients compared to those treated as outpatients has shown a higher proportion of comorbidities, with hypertension, diabetes, and obesity being most prevalent, said Agan. In fact, their findings have begun to identify why obesity is a risk factor for more severe disease.

They were also able to garner valuable insight into the risk of reinfection from a military health care worker enrolled in the study who was reinfected with a symptomatic case of COVID-19. 

“A median time to recovery has been identified as 14 days, with nine lost duty days among active-duty service members,” said Agan. “These findings not only support operational planning, but also provide an important baseline to evaluate the effectiveness of vaccines as uptake widens across the DOD.”

They also found that the antibody levels that cause immunity remain in individuals for more than six months post-infection and that there were no “seroreversions” after six months post-infection. Seroreversion is the loss of serologic reactivity, or the presence of a particular antigen in the blood, whether spontaneous or in response to therapy. 

“With ongoing concerns about the magnitude and duration of immunity post-infection, our findings were both surprising and a relief,” said Burgess.

The researchers hope the information on the effectiveness and safety of the vaccines will alleviate concerns and encourage individuals to be vaccinated. And as the vaccine rollout expands to more recipients, the study will benefit from recruiting participants among the growing population of vaccinated recipients.

“This will enhance our ability to evaluate vaccine effectiveness in the population and if other reports showing high levels of protection are confirmed, our work may help boost confidence among those who are less certain,” said Burgess. “We are excited about the ability of the EPICC study to answer key questions for patients, health care providers, and leadership to guide decisions as we steer through the coming months of this unprecedented and historic pandemic.

You also may be interested in...

Get Your Flu Shot

Video
10/4/2022
Get Your Flu Shot

Rear Adm. Brandon L. Taylor, Director of DHA Public Health, discusses how vaccines greatly reduce the risk of severe disease, hospitalization, and death. "An ounce of prevention is better than a pound of cure." Lets us join Rear Adm. Taylor this year to get informed on how vaccines can minimize the dangers of flu.

Recommended Content:

Public Health | Immunizations | Immunization Healthcare Division | Seasonal Influenza Vaccine

DHA Form 116: Pediatric and Adult Influenza Screening and Immunization Documentation

Form/Template
9/14/2022

A form for screening both children and adults for contraindications to receiving influenza vaccine. (v3, September 2022)

Recommended Content:

Immunizations | Influenza, Northern Hemisphere | Influenza, Southern Hemisphere

DHA Form 207: COVID-19 Vaccine Screening and Immunization Document v22

Form/Template
9/9/2022

The purpose of this form is to determine if the COVID-19 vaccine can be administered to the patient. (v22, Sept. 2022)

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Immunization Healthcare Division | COVID-19 Vaccine Efforts | COVID-19 Information for Military Treatment Facility Directors | Coronavirus

Ramstein Now Offers Novavax Vaccine

Article Around MHS
9/8/2022
Military medical gives Soldier a COVID-19 vaccine

The 86th Medical Group is now offering the Novavax COVID-19 vaccine, which has been authorized for emergency use by the U.S. Food and Drug Administration, to members 18 years and older in the Kaiserslautern Military Community.

Recommended Content:

Immunization Healthcare Division | COVID-19 Vaccine Efforts | Immunizations | Coronavirus

Novavax COVID-19 Vaccine Now Available for 12 to 17 Year-Olds

Article
8/30/2022
Air Force Staff. Sgt. fills a syringe with a COVID-19 vaccine at Ramstein Air Base, Germany.

Novavax COVID-19 Vaccine is Available for Those 12 Years' Old and Above

Recommended Content:

Coronavirus and the COVID-19 Vaccine | COVID-19 Vaccine Efforts

New COVID-19 Boosters Against Subvariants Coming Soon

Article
8/29/2022
Marine on right gets a COVID-19 booster vaccination from a nursing student on his left.

Brooklyn Marine gets COVID-19 booster vaccination.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | COVID-19 Vaccine Efforts

Consolidated Department of Defense Coronavirus Disease 2019 Force Health Protection Guidance

Policy

Consolidates and updates the Department’s guidance regarding vaccination verification, vaccination status, COVID-19 testing, surveillance and screening testing, personnel protection on-site mask requirements, (e.g., DHA military medical treatment facilities, meetings, travel), and the protection of personally identifiable information.

COVID-19 Moderna and Pfizer Vaccines

Publication
8/17/2022

Moderna and Pfizer mRNA vaccines are available. Moderna includes two doses, 28 days apart. Pfizer includes two doses, 21 days apart. Remember to mark your calendar and schedule time for your second dose

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines | Types of COVID-19 Vaccines | Coronavirus & the MHS Response

COVID-19 Moderna Vaccine

Publication
8/17/2022

Moderna and mRNA vaccines are available. Moderna includes two doses, 28 days apart.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines | Types of COVID-19 Vaccines | Coronavirus & the MHS Response

COVID-19 Pfizer Vaccine

Publication
8/17/2022

Pfizer mRNA vaccines are available. Pfizer includes two doses, 21 days apart.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines | Types of COVID-19 Vaccines | Coronavirus & the MHS Response

Learn the Most Recent Age Requirements for COVID-19 Vaccines and Boosters

Article
8/10/2022
A man fist bumps a child.

The best way to prevent the spread of COVID-19 is to get your vaccines and booster shots.

Recommended Content:

Coronavirus & the MHS Response | COVID-19 Vaccine Efforts

Telemedicine Privilege by Proxy Expands Access to MHS Care

Article
8/10/2022
Infographic featuring Lt Col Legault

MHS has Telemedicine Privilege by Proxy: A fast, efficient process that enables providers to file one application and get permission to virtually treat patients anywhere in the MHS.

Recommended Content:

Coronavirus & the MHS Response | Telehealth Program

Whole Health System Approach to Long COVID

Publication
8/1/2022

The U.S. Department of Veterans Affairs Veterans Health Administration is leading an effort to equip health care providers with a Veteran-centered Whole Health System approach to caring for Veterans with Long COVID, also known as post-COVID-19 conditions.

Recommended Content:

COVID-19 Information for Military Treatment Facility Directors | Coronavirus & the MHS Response | Coronavirus

5 Health Care Checkups for Your Child Before School Starts

Article Around MHS
7/28/2022
Boy with backpack shopping

Plan your Child's Check-Up before school starts.

Recommended Content:

Children's Health | Immunizations | Back to School Immunizations

Be Prepared with Back-to-School Immunizations

Video
7/28/2022
Be Prepared with Back-to-School Immunizations

Air Force Surgeon General Miller encourages parents to get their kids immunized before heading back to school in the fall.

Recommended Content:

Medical and Dental Preventive Care Fitness | Children's Health | Immunizations | Back to School Immunizations
<< < 1 2 3 4 5  ... > >> 
Showing results 1 - 15 Page 1 of 31
Refine your search
Last Updated: September 27, 2022
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery